Preferential prescribing of linagliptin in type 2 diabetes patients in an expanded post‐marketing surveillance study in Japan

AIMS/INTRODUCTION: To evaluate linagliptin prescribing in type 2 diabetes mellitus patients with different comorbidities, an expanded Japanese post‐marketing surveillance also collected baseline data for patients initiating other glucose‐lowering drugs. MATERIALS AND METHODS: Patients initiating lin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Diabetes Investig
Autores principales: Fazeli Farsani, Soulmaz, Taniguchi, Atsushi, Ikeda, Rie, Brodovicz, Kimberly G, Bartels, Dorothee B
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2019
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6717825/
https://ncbi.nlm.nih.gov/pubmed/30667173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.13012
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares